This inventor holds 2 USPTO granted patents. Top assignee: University of Bern. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2009
Title: Innovations by Hans Rink in Cancer Treatment
Introduction
Hans Rink is an accomplished inventor based in Bubendorf, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, Rink's work focuses on the application of somatostatin analogues in treating cancerous diseases.
Latest Patents
Rink's latest patents include a treatment process using somatostatin analogues. This method involves characterizing a disease by an overexpression of one or more somatostatin receptors. The process exposes these receptors to a pharmaceutical composition that includes a somatostatin analogue, which binds to the receptors. The patent outlines various components of the somatostatin analogue, including options for chelators and amino acids that enhance its effectiveness in targeting cancer cells.
Another notable patent by Rink is a composition of somatostatin analogues. This composition also features a general formula that includes various chelators and amino acids. The innovative design of these analogues aims to improve the efficacy of cancer treatments by utilizing specific molecular structures that interact with somatostatin receptors.
Career Highlights
Hans Rink is affiliated with the University of Bern, where he conducts his research and develops his patented technologies. His work has garnered attention in the scientific community for its potential to revolutionize cancer treatment methodologies. Rink's dedication to advancing medical science is evident in his innovative approaches to drug development.
Collaborations
Rink collaborates with Helmut Robert Maecke, a fellow researcher who shares his passion for cancer treatment innovations. Their partnership has led to significant advancements in the understanding and application of somatostatin analogues in clinical settings.
Conclusion
Hans Rink's contributions to cancer treatment through his patented innovations highlight the importance of research and development in the medical field. His work continues to inspire future advancements in therapeutic strategies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile